YARROW BIOSCIENCE, INC. Restricted Cash and Cash Equivalents
YARROW BIOSCIENCE, INC. (YARW) had Restricted Cash and Cash Equivalents of $0 as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2025-08-14
- 2025-06-30: Restricted Cash and Cash Equivalents $0.00.
- 2025-03-31: Restricted Cash and Cash Equivalents $0.00.
- 2024-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2024-09-30: Restricted Cash and Cash Equivalents $47.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 |
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2024-09-30 | $47.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $46.00K 10-Q · filed 2025-08-14 |
| 2024-03-31 | $54.00K 10-Q · filed 2025-05-08 |
| 2023-12-31 | $54.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $54.00K 10-Q · filed 2024-11-07 |
| 2023-06-30 | $67.00K 10-Q · filed 2024-08-14 |
| 2023-03-31 | $67.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $67.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | $67.00K 10-Q · filed 2023-11-13 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2022-03-31 | $605.00K 10-Q · filed 2023-05-11 |
| 2021-12-31 | $605.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $605.00K 10-Q · filed 2022-11-14 |
| 2021-06-30 | $605.00K 10-Q · filed 2022-08-12 |
| 2021-03-31 | $855.00K 10-Q · filed 2022-05-12 |
| 2020-12-31 | $855.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $855.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $855.00K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $855.00K 10-Q · filed 2021-05-06 |
| 2019-12-31 | $825.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-05 |
| 2019-06-30 | $250.00K 10-Q · filed 2020-08-06 |
| 2019-03-31 | $250.00K 10-Q · filed 2020-05-11 |
| 2018-12-31 | $250.00K 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |